Watch the full video on Youtube!

i2TRON  is a highly innovative PhD training program on “integrating immune strategies for Translational Research in Oncology and Neurology” and is supported by the Luxembourg National Research Fund (FNR) within their PRIDE program. We will develop the next generation of translational scientists as boundary crossers, domain experts and skilled communicators.

LIH scientists were triumphant in more than one category at the Luxembourg National Research Fund (FNR) awards 2021. In a ceremony that took place in Belval, Luxembourg Institute of Health (LIH) researchers Prof Dr Simone Niclou, Director of the Department of Oncology and group leader of the NORLUX Neuro-Oncology Laboratory and Dr Anna Golebiewska, group leader of the NORLUX Neuro-Oncology Laboratory, received the highly prestigious Outstanding Scientific Achievement award. In addition, Dr Pablo Elias Morande of the LIH Tumor Stroma Interactions group, was bestowed the Outstanding Mentor award.

The IT-X-HD unit aims to provide high quality IT and data analysissolutions for researchers and principal investigators at LIH. By joining ourteam, you will be involved in projects concerning public health research andvarious other support activities for our national partners, e.g. the Ministry ofHealth. As IT Test Automation / Web Developer, you will be designing, developing, running and/or maintaining tests for the various software developed by the unit (manual or automated tests) You will be working in close collaboration with the developers and the different support and platform teams to improve the quality of the implemented solutions and you will supporting the developers in the development of web applications if necessary.

To be part of the “Deep Digital Phenotyping Research Unit” (Group Leader: Dr. G. Fagherazzi) within the Department of Population Health at the LIH, we are currently looking for a Master Student in Data Science / Bioinformatics / Health IT

The Tumor Immunotherapy and Microenvironment (TIME) research group of the LIH Department of Oncology (DONC) teamed-up with Advanced BioDesign to develop innovative combinatorial immunotherapy approaches. The aim is to potentiate the effectiveness of immunotherapy and provide a ground-breaking approach to treat cancers.

Researchers from the LIH Department of Population Health (DoPH) – namely Dr Ala’a Alkerwi and Dr Maria Ruiz-Castell – Gwenaëlle Le Coroller from the LIH Competence Center for Methodology and Statistics (CCMS) and Prof Laetitia Huiart contributed to a collective study on hypertension with data from the national population-based studies “ORISCAV-LUX” (Observation des Risques et de la Santé Cardiovasculaire au Luxembourg) and “EHESLUX” (European Health Examination Survey in Luxembourg). This research, led by Imperial College London in the framework of the international Non-Communicable Diseases Risk Factor Collaboration (NCD-RisC), aimed to understand whether improvements in hypertension detection, treatment and control have been achieved between 1990 and 2019. Available data on this matter are often subject to methodological differences, making it difficult to compare such aspects among multiple countries. Thus, this study aimed to deliver consistent, solid and comparable data on a national, regional and global level. The results were published in August 2021 in the notorious journal The Lancet.

The Luxembourg Institute of Health is organising this free webinar series “Precision Public Health” to reflect on the transition that is currently happening from traditional Population Health to Precision Public Health. Join us in this weekly 4-part series starting November 16, 2021.